# K261707: MEMO 4D Curve™ Semirigid mitral annuloplasty ring

- Pathway: 510(k) (Special)
- Applicant: Corcym S.r.l.
- Decided: Jun 18, 2026 after 27 days
- Product code: KRH (Ring, Annuloplasty)
- Device class: 2
- Regulation: 21 CFR 870.3800
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 5 generations back to K926138 (1993). 8 ancestors in all.
No later device cites it as a predicate yet.
0 of 9 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K230318: Memo 3D Semirigid Annuloplasty Ring; Memo 3D ReChord Semirigid Annuloplasty Ring; Memo 4D Semirigid Annuloplasty Ring, Corcym S.r.l. (2023) Summary page 5.

## Indications for use
MEMO 4D Curve is indicated for use in patients suffering from congenital or acquired mitral insufficiencies or steno-insufficiencies with dilatation and/or deformation of the mitral annulus.

Source page: https://510kreport.com/device/K261707
Methodology: https://510kreport.com/methodology